NCT03074552View on ClinicalTrials.gov

Probiotic Prophylaxis for Microbiome Modulation and VAP or Infections Prevention in Multitrauma Patients

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

August 19, 2017

Primary Completion Date

November 15, 2020

Study Completion Date

December 15, 2020

Conditions
Ventilator Associated PneumoniaInfectionTrauma
Interventions
DIETARY_SUPPLEMENT

LactoLevure

The probiotic preparation will consist a combination of four probiotics: Lactobacillus acidophilus LA-5 1.75 × 109 CFU, Lactobacillus Plantarum 0.5 × 109 CFU, Bifidobacterium lactis BB-12 1.75 × 109 CFU και Saccharomyces boulardii 1.5 × 109 CFU per capsule (LactoLevure, UniPharma, Athens, Greece).

OTHER

Placebo

Placebo will consist of identical capsules of powdered glucose polymer

Trial Locations (1)

56346

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
collaborator

Uni-Pharma

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER

NCT03074552 - Probiotic Prophylaxis for Microbiome Modulation and VAP or Infections Prevention in Multitrauma Patients | Biotech Hunter | Biotech Hunter